Point-of-care testing: promises and challenges October 13th, 2023 Point-of-care testing (POCT) has long been touted as a revolutionary technology that has the potential to transform healthcare. By providing fast, convenient, and affordable testing options, POCT can help to improve patient care and reduce costs Clearstate Insights In-vitro diagnosticsPoint-of-care testing (POCT)Uncategorised
Spine trends in orthopaedics September 28th, 2023 The Southeast Asia (SEA) market witnessed significant double-digit growth in spinal procedure volumes from 2021-22, due to the lifting of covid-19 restrictions and fewer backlog surgeries. Clearstate’s report highlights the competitive landscape and trends shaping the region’s orthopaedic spinal market. Campaign Orthopaedic & Spine SurgeryAsia
Trends shaping the IVD demand in emerging markets September 27th, 2023 Clearstate’s latest infographic looks at the micro and macro economic trends influencing the future of IVD demand in emerging markets in APAC and LATAM. Campaign In-vitro diagnosticsGlobal
Orthopaedics: trauma trends in SEA – Thank you August 15th, 2023 Lifted restrictions post-covid-19 increased traffic accidents in SEA markets (particularly in Malaysia, Indonesia and Thailand) and led to an increase in fracture volumes, with double-digit growth observed from 2021 to 2022. Campaign Orthopaedic & Spine SurgerySurgical deviceAsia
Orthopaedics: trauma trends in SEA August 15th, 2023 Lifted restrictions post-covid-19 increased traffic accidents in SEA markets (particularly in Malaysia, Indonesia and Thailand) and led to an increase in fracture volumes, with double-digit growth observed from 2021 to 2022. Campaign Orthopaedic & Spine SurgerySurgical deviceAsia
Inside APAC’s IVD market July 31st, 2023 Over the past two years, the global in-vitro diagnostics (IVD) sector has experienced various shifts and developments. The pandemic’s far-reaching impact across economies and healthcare systems has affected everything from IVD testing trends, to laboratory capacities. As covid-19 becomes endemic, IVD companies are reassessing their priorities based on future growth opportunities and challenges. Campaign UncategorisedAsia
Orthopaedics: joint replacement trends in SEA – Thank you July 21st, 2023 As the covid-19 pandemic transitioned into an endemic phase, individuals resumed seeking medical treatment, leading to an increase in elective procedures. In Southeast Asia* (SEA), there was a significant growth in joint replacement procedure volumes, with double-digit growth observed from 2021 to 2022. Campaign
Orthopaedics: joint replacement trends in SEA July 21st, 2023 As the covid-19 pandemic transitioned into an endemic phase, individuals resumed seeking medical treatment, leading to an increase in elective procedures. In Southeast Asia* (SEA), there was a significant growth in joint replacement procedure volumes, with double-digit growth observed from 2021 to 2022. Campaign Orthopaedic & Spine SurgerySurgical deviceGlobal
Segment Trend Report Understand the high-level segment value and trends driving market demand of main IVD segments, then these Segment Trend reports would meet your needs. Solutions
Growth opportunities for IVD companies in APAC and LATAM June 19th, 2023 Growth opportunities from covid-19 have helped fuel rapid expansion for both established and emerging IVD companies. IVD companies have tapped into the increased global demand to drive growth, with some companies doubling their revenues during the pandemic years. Campaign Centralised Diagnostics (CEDx)In-vitro diagnosticsPoint-of-care testing (POCT)Tissue Diagnostics (TDx)AmericasAsia
How impactful is your exhibitor booth going to be at AACC? June 13th, 2023 Navigating the complex dynamics of conference exhibitions is an investment, involving costs related to staff training and travel, marketing content, booth design, and added features and zones such as the inclusion of a medical corner. To justify these expenses and understand where to channel future investments, it’s crucial to measure the impact and effectiveness of your exhibition booth in a quantitative, data-driven way. Case study In-vitro diagnosticsUncategorisedGlobalIVD GatewayLabPRO PlusSize and Share Plus
Six facts to know about Australia’s infectious disease market June 9th, 2023 Infectious disease testing in Australia is undergoing major transformations. Health policy, clinical practices and supplier landscape are causing a shift in testing technology. Campaign In-vitro diagnosticsInfectious Diseases Testing MonitorTissue Diagnostics (TDx)Global